Relation of low-grade inflammation and endothelial activation to blood pressure in obese children and adolescents

Neuroendocrinology Letters

Volumn 27, Issue 4, 2006, Pages 459-464

  Syrenicz, Anhelli ^a   Garanty Bogacka, Barbara ^a   Syrenicz, Małgorzata ^a   Gebala, Aneta ^a   Dawid, Grazyna ^a   Walczak, Mieczysław ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Blood pressure; Children; Endothelial activation; Inflammation; Obesity

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHILD; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OBESITY; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

EID: 33845976714     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Barbieri M, Ferrucci L, Corsi AM, Macchi C, Lauretani F, Bonafe M, Olivieri F, Giovagnetti S, Franceshi C, Paolisso G. Is chronic inflammation a determinant of blood pressure in the elderly? Am J Hypertens 2003; 16: 537-543.
2. Bjorntorp P, Holm G, Rosmond R, Folkow B. Hypertension and the metabolic syndrome: closely related central origin. Blood Press 2000; 9:71-82.
3. Bonafe M, Olivieri F, Cavallone L, Giovagnetti S, Marchegiani F, Cardelli M, Pieri C, Marra M, Antonicelli R, Lisa R, Rizzo MR, Paolisso G, Monti D, Franceshi C. A gender dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 2001; 31: 2357-2361.
4. Campese VM, Ye S, Zhong H. Down regulation of neuronal nitric oxide synthase and interleukin-1 beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2002; 39: 519-524.
5. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38: 399-403.
6. Daniels SR, Morrison JA, Sprecher DL, Khoury P, Kimball TR. Association of body fat distribution and cardiovascular risk factors in children and adolescents. Circulation 1999; 99: 541-545.
7. DeSouza CA, Van Guilder GP, Greiner JJ, Smith DT, Hoetzer GL, Stauffer BL. Basal endothelial nitric oxide release is preserved in overweight and obese adults. Obes Res 2005; 13: 1303-1306.
8. Fernandez Real JM, Vayrecla M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W. Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in appoarently healthy men and women. J Clin Endocrinol Metab 2001; 86:1154-1159.
9. Gimbrone MA, Nagel T, Topper JN. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest 1997;99:1809-1813.
10. Hall JE, Hidebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 2001; 14 (Part 2): 103S-115S.
11. Hall JE. The kidney, hypertension, and obesity. Hypertension 2003;41:625-633.
12. Humpries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6-174G/ C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001; 22: 2243-2252.
13. Ighetti L, Bedogni G, Ferrari M. Is fasting insulin associated with blood pressure in obese children? Ann Hum Biol 2000; 27: 499-506.
14. Ikeda U, Ikeda M, Oohara T, Ohuchi A, Kamitani T, Tsuruya Y, Kano S. Inteleukin-6 stimulates growth of vascular smooth muscle cells in a PDGF dependent manner. Am J Physiol 1991; 260: H1713-H1717.
15. Lesperance F, Frasure-Smith N, Theroux P, Irwin M. The association between major depression and levels od soluble intercellular adhesion molecule-1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndrome. Am J Psychiatry 2004;161:271-277.
16. Li JJ, Fang CH, Hui RT. Is hypertension an inflammatory disease? Med Hypotheses 2005; 64: 236-240.
17. Liu Y, Liu T, McCarron RM, Spatz M, Feuerstein G, Hallenbeck JM, Siren AL. Evidence for activation of enclothelium and monocyte in hypertensive rats. Am J Physiol 1996; 270: H2125-H2131.
18. Manrique C, Lastra G, Whaley-Connell A, Sowers JR. Hypertension and the cardiometabolic syndrome. J Clin Hypertens (Greenwich) 2005;7:471-476.
19. Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG. Obesity-induced hypertension. New concepts from the emerging biology of obesity. Hypertension 1999; 33: 537-541.
20. Meyer AA, Kundt G, Steiner M, Schuff-Werner P, Kienast W. Impaired flow-mediated vasoclilatation, caroid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors. Pediatrics 2006;117:1560-1567.
21. National High Blood Pressure Education Programme Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Programme. Pediatrics 1996;98:649-658.
22. Palczewska I, Niedźwiecka Z. Somatic development indices in children and youth of Warsaw. Developmental Period Medicine 2001; 2 (suppl. 11): 113-114.
23. Peeters AC, Netea MG, Janssen MC, Kullberg BJ, Van Der Meer JW, Thien T. Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest 2001; 31: 31-36.
24. Ross R. Atherosclerosis: an inflammatory disease. N Eng J Med 1999;340:115-126.
25. Williams IL, Chowienczyk PJ, Wheatcroft SB, Patel AG, Sherwood RA, Momin A et al. Endothelial function and weight loss in obese humans. Obes Surg 2005; 15: 1055-1060.
26. Yudkin JS. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes 2003; 27: S25-S28.